Despite Proven Success at Preventing Cancer, Physicians Report High Refusal Rates for HPV Vaccine
The HPV vaccine is one of only two vaccines that prevent cancer but is underutilized in the United States. Despite its proven success at preventing…
Vaccine
New Skin Patch Could Quickly and Painlessly Deliver Vaccines and Cancer Medications
Melanoma is a deadly form of skin cancer that has been increasing in the U.S. for the past 30 years. Nearly 100,000 new cases of…
Technical Advances Provide Big Improvements in HIV Vaccine Production
Research on HIV over the past decade has led to many promising ideas for vaccines to prevent infection by the AIDS virus, but very few…
Programmable RNA Nanoparticles Could Protect Against the Zika Virus
By programming RNA nanoparticles, researchers from MIT have devised a new vaccine candidate for the Zika virus. The vaccine consists of strands of genetic material…
Triple Sugar Molecule Protects Against the Pneumococcal Strain ST8
Researchers at the Max Planck Institute show that a molecule consisting of three adjoined sugars induces an immune response against Streptococcus pneumoniae. It may not…
Engineers Design Programmable RNA Vaccines That Protext Against Ebola and H1N1 Influenza
A newly published study details how engineers developed programmable RNA vaccines that work against Ebola, H1N1 influenza, and a common parasites in mice. MIT engineers…
New Strategy to Better Protect Cancer Patients from the Flu
Scientists from Yale University have developed a new vaccine strategy that reduces the risk of flu infections in cancer patients at highest risk for influenza….
Researchers One Step Closer to Developing Better Vaccines
Scientists from Yale University have uncovered a new role for regulatory T cells, moving them one step closer to developing vaccines that could be more…
Cell-Squeezing Device Opens New Possibilities for Cell-Based Vaccines
A newly published study details how researchers from MIT developed a new microfluidic cell-squeezing device, opening new possibilities for cell-based vaccines. MIT researchers have shown…
New Study Reveals No Association Between MMR Vaccine and Autism
A newly published study involving 95,000 children reveals that the measles-mumps-rubella vaccine was not associated with an increased risk of autism spectrum disorders, regardless of…
New Anti-HIV Candidate Blocks Every Strain of HIV-1, HIV-2 and SIV
In a new study, researchers show that a new drug candidate blocks every strain of HIV-1, HIV-2 and SIV that has been isolated from humans…
Preprogrammed Immune Cells Can Fight Specific Pathogens
A new study from Cornell University demonstrates a way to grow preprogrammed immune cells that can fight specific pathogens, potentially transforming the methods used to…
Researchers Develop Vaccine to Help Control Autism-Associated Gut Bacteria
Scientists at the University of Guelph have developed a carbohydrate-based vaccine against the gut bug Clostridium bolteae. This is the first vaccine designed to control…
Compound in Panda Blood Could Fight Superbugs
Researchers have discovered a potent antibody in panda blood, which could help fight increasingly prevalent drug-resistant strains of infections. Cathelicin-AM was discovered when researchers analyzed…
3D Printing Using DNA Could Make Drugs
New technology that combines the computer-aided design software inSequio with nanoscale fabrication technology could allow for the 3D printing of drugs using DNA. The Parabon…
Synthesizing a Flu Vaccine Without the Virus
A new vaccine strategy, which uses synthetic messenger RNA (mRNA) instead of proteins purified from viruses, could make flu shots cheaper, safer, and easier to…
Phase III Vaccine Trial in Africa Gives Poor Results about New Malaria Drug
A phase III clinical trial in Africa of the RTS,S/AS01 malaria vaccine has reported disappointing results. The vaccine failed to show substantial protection for infants…
Molecular Bio-Printing of Drugs Could Result in Emailed Vaccines
Emailing biological molecules, using 3D biological printers, might seem like science-fiction, but Craig Venter discussed the idea at the Wired Health Conference in New York….